Joan Nickerson - Feb 15, 2023 Form 3 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Chief Administrative Officer
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Joan Nickerson
Stock symbol
VERV
Transactions as of
Feb 15, 2023
Transactions value $
$0
Form type
3
Date filed
2/23/2023, 04:00 PM
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VERV Common Stock 5.49K Feb 15, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VERV Stock Option (right to buy) Feb 15, 2023 Common Stock 69K $30.94 Direct F1
holding VERV Stock Option (right to buy) Feb 15, 2023 Common Stock 102K $8.98 Direct F2
holding VERV Stock Option (right to buy) Feb 15, 2023 Common Stock 53.2K $21.76 Direct F3
holding VERV Restricted Stock Units Feb 15, 2023 Common Stock 13.3K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on February 11, 2022. 25% of the shares underlying the option vested on February 11, 2023, and the remainder are scheduled to vest in equal monthly installments thereafter until February 11, 2026.
F2 The option was granted on April 1, 2021. 25% of the shares underlying the option vested on April 1, 2022, and the remainder are scheduled to vest in equal monthly installments until April 1, 2025.
F3 The option was granted on February 14, 2023. 25% of the shares underlying the option will vest on February 14, 2024, and the remainder are scheduled to vest in equal monthly installments thereafter until February 14, 2027.
F4 On February 14, 2023, the reporting person was granted 13,260 restricted stock units, vesting in four equal annual installments beginning on April 1, 2024 and the remaining three installments vesting on April 1, 2025, April 1, 2026 and April 1, 2027.
F5 Each restricted stock unit represents a contingent right to receive one share of common stock.

Remarks:

Exhibit Index 24.1 Power of Attorney